Company Filing History:
Years Active: 2010
Title: Angela Glen: Innovator in Pharmaceutical Chemistry
Introduction
Angela Glen, a notable inventor hailing from Suffolk, GB, has made significant strides in the field of pharmaceutical chemistry. With an impressive patent portfolio that showcases her innovative spirit, she works diligently on compounds that have the potential to treat various health conditions.
Latest Patents
Angela holds a patent for "Pyrrolidine derivatives acting as CCR3-receptor antagonists." This patent details compounds formulated in free or salt forms, wherein specific variables (T, X, Y, U, R, R, m, n, and p) are defined in the specification. These compounds are recognized for their effectiveness in treating conditions mediated by CCR3. Additionally, the patent describes various pharmaceutical compositions containing these compounds and outlines processes for their preparation.
Career Highlights
At Novartis AG, Angela Glen contributes her expertise in drug development and patent innovation. Her work on advancing therapeutic compounds illustrates her commitment to enhancing health outcomes. The single patent she holds stands as a testament to her dedication and creativity in the pharmaceutical sector.
Collaborations
Angela collaborates with esteemed colleagues, including Gurdip Bhalay and Andrew Dunstan. Together, they push the boundaries of research and development within their organization, resulting in continued progress in pharmaceutical innovations.
Conclusion
Angela Glen exemplifies the spirit of innovation through her impactful work and contributions to the field of pharmaceutical chemistry. Her patent on pyrrolidine derivatives highlights her ability to create solutions that address significant medical needs, ensuring a positive influence on healthcare and research advancements.